Translate Bio
ID: 5313106Translate Bio is a clinical-stage mRNA therapeutics company developing medicines to treat diseases caused by protein or gene dysfunction and vaccines against infectious disease pathogens.
6
Funding Rounds
$227.7m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi***** He******* | - | - | linkedin facebook |
| An*** Ma******* |
|
- | linkedin twitter |
| Je*********** Fo***** | - | - |
Funding
Funding series
Funding Series Analysis
The company Translate Bio has raised a total of $227.66m in funding over 6 rounds.
Key Insights:
- Translate Bio Venture round, May 3, 2019: $47.5m
- Translate Bio Series C round, December 1, 2017: $42m
- Translate Bio Series C round, January 10, 2017: $51m
- Translate Bio Series B round, July 30, 2015: $63.8m
- Translate Bio Series A round: $20.7m
- Translate Bio funding round, November 2011: $2.66m
Industries
Translate Bio is active in the following industries: